Elevated amniotic fluid interleukin-6 levels during the early second trimester are associated with greater risk of subsequent preterm delivery

Alessandro Ghidini, Chuka B. Jenkins, Catherine Y. Spong, John C. Pezzullo, Carolyn M. Salafia, Gary S. Eglinton

Research output: Contribution to journalArticle

59 Citations (Scopus)

Abstract

Problem: Subclinical intra-amniotic infection is often associated with preterm delivery and may precede it by several weeks. We tested the hypothesis that Interleukin-6 (IL-6) may be elevated in the midtrimester amniotic fluid of pregnancies destined to deliver preterm. Methods: A historical cohort study was designed to compare the amniotic fluid (AF) concentrations of IL-6 at 14-20 weeks in a group of women subsequently delivering at ≤ 34 weeks (n = 13) with those of women delivering at term (n = 166). Included were singleton gestations with no evidence of fetal structural or chromosomal abnormalities, or maternal conditions known to be associated with preterm delivery (n = 179). Levels of IL-6 were measured by immunoassay and correlated with demographic and pregnancy outcome information. Statistical analysis included correlation, one-way ANOVA after log-transformation, contingency tables, logistic regression, and receiver operator characteristic (ROC) curve analysis. Results: There was an inverse correlation between AF IL-6 levels at 15-20 weeks and gestational age at delivery (r = -0.16, P = 0.03). Women delivering at ≤ 34 weeks had significantly higher median AF IL-6 levels (570 pg/ml versus 330 pg/ml, P < 0.0001), rate of African American race (50% versus 12%, P = 0.004), and of infants with birth weights < 10th centile (31% versus 7%, P = 0.02) than women delivering at ≤ 37 weeks. Logistic regression analysis showed that IL-6 was independently associated with PTD at ≤ 34 weeks after controlling for race and birth weight centiles (P = 0.039). Conclusions: AF IL-6 at 15-20 weeks can identify patients at risk for PTD at ≤ 34 weeks, suggesting that a portion of PTD cases have inciting events that take place during the early second trimester.

Original languageEnglish (US)
Pages (from-to)227-231
Number of pages5
JournalAmerican Journal of Reproductive Immunology
Volume37
Issue number3
DOIs
StatePublished - Jan 1 1997
Externally publishedYes

Fingerprint

Second Pregnancy Trimester
Amniotic Fluid
Interleukin-6
Birth Weight
Logistic Models
Pregnancy
Pregnancy Outcome
Immunoassay
Chromosome Aberrations
African Americans
Gestational Age
Analysis of Variance
Cohort Studies
Regression Analysis
Mothers
Demography
Infection

Keywords

  • Cytokines
  • Human pregnancy
  • Preterm delivery

ASJC Scopus subject areas

  • Immunology and Allergy
  • Immunology
  • Reproductive Medicine
  • Obstetrics and Gynecology

Cite this

Elevated amniotic fluid interleukin-6 levels during the early second trimester are associated with greater risk of subsequent preterm delivery. / Ghidini, Alessandro; Jenkins, Chuka B.; Spong, Catherine Y.; Pezzullo, John C.; Salafia, Carolyn M.; Eglinton, Gary S.

In: American Journal of Reproductive Immunology, Vol. 37, No. 3, 01.01.1997, p. 227-231.

Research output: Contribution to journalArticle

Ghidini, Alessandro ; Jenkins, Chuka B. ; Spong, Catherine Y. ; Pezzullo, John C. ; Salafia, Carolyn M. ; Eglinton, Gary S. / Elevated amniotic fluid interleukin-6 levels during the early second trimester are associated with greater risk of subsequent preterm delivery. In: American Journal of Reproductive Immunology. 1997 ; Vol. 37, No. 3. pp. 227-231.
@article{64e0b4cc36c34acf93fcec4aaec8b91f,
title = "Elevated amniotic fluid interleukin-6 levels during the early second trimester are associated with greater risk of subsequent preterm delivery",
abstract = "Problem: Subclinical intra-amniotic infection is often associated with preterm delivery and may precede it by several weeks. We tested the hypothesis that Interleukin-6 (IL-6) may be elevated in the midtrimester amniotic fluid of pregnancies destined to deliver preterm. Methods: A historical cohort study was designed to compare the amniotic fluid (AF) concentrations of IL-6 at 14-20 weeks in a group of women subsequently delivering at ≤ 34 weeks (n = 13) with those of women delivering at term (n = 166). Included were singleton gestations with no evidence of fetal structural or chromosomal abnormalities, or maternal conditions known to be associated with preterm delivery (n = 179). Levels of IL-6 were measured by immunoassay and correlated with demographic and pregnancy outcome information. Statistical analysis included correlation, one-way ANOVA after log-transformation, contingency tables, logistic regression, and receiver operator characteristic (ROC) curve analysis. Results: There was an inverse correlation between AF IL-6 levels at 15-20 weeks and gestational age at delivery (r = -0.16, P = 0.03). Women delivering at ≤ 34 weeks had significantly higher median AF IL-6 levels (570 pg/ml versus 330 pg/ml, P < 0.0001), rate of African American race (50{\%} versus 12{\%}, P = 0.004), and of infants with birth weights < 10th centile (31{\%} versus 7{\%}, P = 0.02) than women delivering at ≤ 37 weeks. Logistic regression analysis showed that IL-6 was independently associated with PTD at ≤ 34 weeks after controlling for race and birth weight centiles (P = 0.039). Conclusions: AF IL-6 at 15-20 weeks can identify patients at risk for PTD at ≤ 34 weeks, suggesting that a portion of PTD cases have inciting events that take place during the early second trimester.",
keywords = "Cytokines, Human pregnancy, Preterm delivery",
author = "Alessandro Ghidini and Jenkins, {Chuka B.} and Spong, {Catherine Y.} and Pezzullo, {John C.} and Salafia, {Carolyn M.} and Eglinton, {Gary S.}",
year = "1997",
month = "1",
day = "1",
doi = "10.1111/j.1600-0897.1997.tb00219.x",
language = "English (US)",
volume = "37",
pages = "227--231",
journal = "American Journal of Reproductive Immunology",
issn = "8755-8920",
publisher = "Wiley-Blackwell",
number = "3",

}

TY - JOUR

T1 - Elevated amniotic fluid interleukin-6 levels during the early second trimester are associated with greater risk of subsequent preterm delivery

AU - Ghidini, Alessandro

AU - Jenkins, Chuka B.

AU - Spong, Catherine Y.

AU - Pezzullo, John C.

AU - Salafia, Carolyn M.

AU - Eglinton, Gary S.

PY - 1997/1/1

Y1 - 1997/1/1

N2 - Problem: Subclinical intra-amniotic infection is often associated with preterm delivery and may precede it by several weeks. We tested the hypothesis that Interleukin-6 (IL-6) may be elevated in the midtrimester amniotic fluid of pregnancies destined to deliver preterm. Methods: A historical cohort study was designed to compare the amniotic fluid (AF) concentrations of IL-6 at 14-20 weeks in a group of women subsequently delivering at ≤ 34 weeks (n = 13) with those of women delivering at term (n = 166). Included were singleton gestations with no evidence of fetal structural or chromosomal abnormalities, or maternal conditions known to be associated with preterm delivery (n = 179). Levels of IL-6 were measured by immunoassay and correlated with demographic and pregnancy outcome information. Statistical analysis included correlation, one-way ANOVA after log-transformation, contingency tables, logistic regression, and receiver operator characteristic (ROC) curve analysis. Results: There was an inverse correlation between AF IL-6 levels at 15-20 weeks and gestational age at delivery (r = -0.16, P = 0.03). Women delivering at ≤ 34 weeks had significantly higher median AF IL-6 levels (570 pg/ml versus 330 pg/ml, P < 0.0001), rate of African American race (50% versus 12%, P = 0.004), and of infants with birth weights < 10th centile (31% versus 7%, P = 0.02) than women delivering at ≤ 37 weeks. Logistic regression analysis showed that IL-6 was independently associated with PTD at ≤ 34 weeks after controlling for race and birth weight centiles (P = 0.039). Conclusions: AF IL-6 at 15-20 weeks can identify patients at risk for PTD at ≤ 34 weeks, suggesting that a portion of PTD cases have inciting events that take place during the early second trimester.

AB - Problem: Subclinical intra-amniotic infection is often associated with preterm delivery and may precede it by several weeks. We tested the hypothesis that Interleukin-6 (IL-6) may be elevated in the midtrimester amniotic fluid of pregnancies destined to deliver preterm. Methods: A historical cohort study was designed to compare the amniotic fluid (AF) concentrations of IL-6 at 14-20 weeks in a group of women subsequently delivering at ≤ 34 weeks (n = 13) with those of women delivering at term (n = 166). Included were singleton gestations with no evidence of fetal structural or chromosomal abnormalities, or maternal conditions known to be associated with preterm delivery (n = 179). Levels of IL-6 were measured by immunoassay and correlated with demographic and pregnancy outcome information. Statistical analysis included correlation, one-way ANOVA after log-transformation, contingency tables, logistic regression, and receiver operator characteristic (ROC) curve analysis. Results: There was an inverse correlation between AF IL-6 levels at 15-20 weeks and gestational age at delivery (r = -0.16, P = 0.03). Women delivering at ≤ 34 weeks had significantly higher median AF IL-6 levels (570 pg/ml versus 330 pg/ml, P < 0.0001), rate of African American race (50% versus 12%, P = 0.004), and of infants with birth weights < 10th centile (31% versus 7%, P = 0.02) than women delivering at ≤ 37 weeks. Logistic regression analysis showed that IL-6 was independently associated with PTD at ≤ 34 weeks after controlling for race and birth weight centiles (P = 0.039). Conclusions: AF IL-6 at 15-20 weeks can identify patients at risk for PTD at ≤ 34 weeks, suggesting that a portion of PTD cases have inciting events that take place during the early second trimester.

KW - Cytokines

KW - Human pregnancy

KW - Preterm delivery

UR - http://www.scopus.com/inward/record.url?scp=0030891110&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0030891110&partnerID=8YFLogxK

U2 - 10.1111/j.1600-0897.1997.tb00219.x

DO - 10.1111/j.1600-0897.1997.tb00219.x

M3 - Article

C2 - 9127643

AN - SCOPUS:0030891110

VL - 37

SP - 227

EP - 231

JO - American Journal of Reproductive Immunology

JF - American Journal of Reproductive Immunology

SN - 8755-8920

IS - 3

ER -